ArticleClinical and translational science2022

Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer.

Carlos Gomez-Roca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.